Learn more

ZENTARIS GMBH

Overview
  • Total Patents
    580
About

ZENTARIS GMBH has a total of 580 patent applications. Its first patent ever was published in 1992. It filed its patents most often in Argentina, EPO (European Patent Office) and Norway. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are G D SEARLE & AMP, KARUS THERAPEUTICS LTD and TSENTARIS GMBKH.

Patent filings per year

Chart showing ZENTARIS GMBHs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Guenther Eckhard 103
#2 Baasner Silke 77
#3 Gunther Eckhard 71
#4 Engel Juergen 71
#5 Emig Peter 70
#6 Schmidt Peter 69
#7 Gerlach Matthias 52
#8 Kutscher Bernhard 51
#9 Reissmann Thomas 50
#10 Nickel Bernd 48

Latest patents

Publication Filing date Title
EP1800684A1 Novel alkyl phospholipid derivatives and uses thereof
MX2007007238A Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder
EP1790342A1 Pyridopyrazine derivatives and their use as signal transduction modulators
EP1785423A1 Pyridopyrazine derivatives and their use as kinase modulators
EP1757290A1 Novel triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors
UA89963C2 Tetrahydrocarbazole derivatives with improved biological action and improved solubility as ligands for g-protein coupled receptors (gpcrs)
US2005267303A1 Cyclic indole and heteroindole derivatives and methods for making and using as pharmaceuticals
EP1674082A1 Process for the manufacture of sterile suspensions or lyophilisates of low-soluble basic peptide complexes, pharmaceutical formulations comprising these complexes and their use as medicament
IL165440D0 Arylcarbonylpiperazines and heteroarylpiperazines and the use thereof for treating benign and malignant tumour diseases
US7211588B2 N-substituted indolyl-3-glyoxylamides, their use as medicaments and process for their preparation
DE102004033902A1 New tetrahydrocarbazole compounds are neurokinin-1 receptor antagonists useful to treat or prevent e.g. pubertas praecox, hirsutism, polycystic ovary syndrome, hormone dependent neoplastic diseases and Alzheimer's disease
CA2528938A1 Compounds having inhibitive activity of phosphatidylinositol 3-kinase and methods of use thereof
US7205299B2 Indole derivatives having an apoptosis-inducing effect
TW200504013A Indole derivatives having an apoptosis-inducing effect
UA86021C2 Indole derivatives with apoptosis-inducing effect
RS20050901A Indole derivatives with apoptosis- inducing effect
EP1595878A1 Indole derivatives with apoptosis inducing activity
DE102004022383A1 New pyridopyrazine derivatives are modulators of kinase activity, useful for the treatment of diseases associated with abnormal cellular signaling, e.g. tumors
UA83996C2 Pharmaceutical gel preparation comprising peptides, method for producing thereof, kit for producing and use thereof
MXPA05003318A Administration form for pharmaceutically active peptides with sustained release and method for the production thereof.